Quantum Dots Fluorescence Immunoassay Kits

Dedicated quantification assay kits for nucleic acids and proteins designed for use with fluorescence-based quantification systems. Provides high-sensitivity measurement capabilities for routine and specialized laboratory quantification needs.

Fluorescence immunoassay POCT rapid diagnostic kits for point-of-care testing, enabling quick detection of biomarkers at the bedside or clinical setting. These kits utilize fluorescence technology to deliver sensitive and specific results without requiring centralized laboratory infrastructure, supporting rapid clinical decision-making.

Immuno-dot based diagnostic test kits for rapid pathogen or biomarker detection. Tests are economical alternatives to ELISA for low-throughput applications. Results available within 3 to 30 minutes without requiring specialized laboratory infrastructure.

Point-of-care test kits utilizing immunofluorescence technology for rapid diagnostic applications. These kits are designed for quick and efficient diagnostic testing in clinical settings.

POCT dry fluorescence immunoassay test kits and immunoanalyzer for rapid point-of-care diagnostics. Designed for hematology and clinical chemistry applications with integrated reagent, calibrator, and control solutions. CE and ISO 13485 certified with compatibility across leading analyzer platforms.

A platform for immune diagnosis devices based on Quantum Dot fluorescence measurement mode technology. It includes Quantum Dot labeled detection kits for enhanced sensitivity, precise analysis, and multiplex analysis capabilities. The platform offers both Gold Type and Quantum Dot Type kits with sensitivity down to ng/ml levels and 500-1,000 fold higher accuracy compared to gold standard detection methods.

Multi-parameter fluorescence immunoassay diagnostic test kits enabling point-of-care testing for 20+ clinical parameters. These POCT reagents provide rapid, sensitive detection across infectious disease, cardiac, and metabolic markers, supporting timely clinical decision-making in resource-limited and acute care settings.

Fluorescent-labeled reagent kits for immunofluorescence microscopy-based detection of antigens in tissue and cell samples. Enables specific visualization and identification of target pathogens and disease markers.

Infectious disease detection kits utilizing microfluidic chip, fluorescence quantitative PCR, and isothermal amplification technologies for rapid pathogen identification and diagnosis. Designed for epidemic screening, disease diagnosis, and clinical monitoring across multiple infectious disease applications.

Gold standard immunochromatographic assay kits for rapid diagnostic testing. Utilizes colloidal gold technology for qualitative and semi-quantitative detection in clinical applications.

In vitro diagnostic test kits based on microarray chemiluminescence immunoassay technology. These kits employ hard substrate glass slides with covalently bound monoclonal antibodies, enabling parallel testing of multiple biomarkers with enhanced sensitivity and accuracy.

Diagnostic test kits utilizing fluorescence immunoassay technology for rapid detection of various health conditions. These tests are companion products to the fluorescence analyzer platform.